Advertisement
The U.S. Food and Drug Administration emergency approval of blood plasma as a COVID-19 treatment was put on hold last week after senior federal health officials said data supporting the therapy were too weak.

FDA Emergency Approval on Hold for Blood Plasma to Treat COVID-19

0
More data are under review; the approval could still be issued in the near future
From 2005 to 2016

Mortality Down but Health Care Costs Up From Gun Violence

0
Head and neck, vascular, gastrointestinal surgery independently linked to high cost tertile designation
In a potential harbinger of what could unfold on college campuses across the United States this fall

COVID-19 Spread Among Students Prompts UNC to Return to Online Teaching

0
University was one of the largest schools in the country to bring students to campus for in-person teaching
COVID-19 cases in U.S. nursing homes rose nearly 80 percent earlier this summer

COVID-19 Cases Rebound Sharply in U.S. Nursing Homes

0
By mid-July, nursing homes across the Sunbelt region accounted for 69 percent of COVID-19 deaths
Patient visitation policies and clinician communication methods in hospitals have undergone a major overhaul

Hospital Visitation, Communication Policies Evolving Due to COVID-19

0
New research reveals trends of visitor restrictions and smartphone communication in Michigan hospitals
For patients hospitalized with COVID-19

CV Risk Factors, Comorbidity Tied to COVID-19 CV Complications

0
Significant interaction with death seen for preexisting CV comorbidities or risk factors, CV complications during hospitalization
The novel coronavirus is surging once more in U.S. nursing homes

COVID-19 Deaths in Nursing Homes Climbing Again

0
Number of new cases in nursing homes climbed to 8,628 for the week of July 19
Excess mortality during the peak of the 1918 H1N1 influenza pandemic was comparable to that seen early in the COVID-19 pandemic outbreak in New York City

Excess Mortality During Peak of 1918 Flu Similar to COVID-19 in NYC

0
Incidence rate ratio for all-cause mortality 0.70 during peak of 1918 H1N1 flu, early COVID-19
Transfusion of convalescent plasma is efficacious in patients with severe COVID-19

Convalescent Plasma Efficacious for Severe COVID-19

0
Significant reduction seen in mortality, specifically among patients transfused with plasma within 72 hours
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Aug. 10 to 14

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...